New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 26, 2012
05:55 EDTAMD, AMD, AMD, AMD, AMD, VAR, VAR, VAR, VAR, VAR, RDNT, RDNT, RDNT, RDNT, RDNT, PKI, PKI, PKI, PKI, PKI, NTAP, NTAP, NTAP, NTAP, NTAP, MDT, MDT, MDT, MDT, MDT, HOLX, HOLX, HOLX, HOLX, HOLX, EMC, EMC, EMC, EMC, EMC, DELL, DELL, DELL, DELL, DELL, CERN, CERN, CERN, CERN, CERN, AWRE, AWRE, AWRE, AWRE, AWRE, ATHN, ATHN, ATHN, ATHN, ATHN, T, T, T, T, T, VMW, VMW, VMW, VMW, VMWRadiological Society of North America hosts a conference
RSNA 2012 is being held in Chicago on November 25-30.
News For AMD;T;ATHN;AWRE;CERN;DELL;EMC;HOLX;MDT;NTAP;PKI;RDNT;VAR;VMW From The Last 14 Days
Check below for free stories on AMD;T;ATHN;AWRE;CERN;DELL;EMC;HOLX;MDT;NTAP;PKI;RDNT;VAR;VMW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
August 7, 2014
08:58 EDTMDTMedtronic receives request of additional info from FTC for Covidien acquisition
On August 6, 2014, in connection with the FTC review of the pending acquisition by Medtronic (MDT) of Covidien (COV), which will result in both Medtronic and Covidien becoming wholly owned subsidiaries of Medtronic, Medtronic received a request for additional information and documentary material from the FTC. Issuance of the second request extends the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 until 30 days after Medtronic and Covidien have substantially complied with the second request, unless the waiting period is extended voluntarily by the parties or terminated earlier by the FTC. Medtronic and Covidien intend to cooperate fully with the FTC and continue to expect the Transaction to be completed in the fourth calendar quarter of 2014 or early 2015.
08:27 EDTNTAPNetApp price target raised to $46 from $41 at Pacific Crest
Pacific Crest raised its price target on NetApp as the firm thinks the stock will be boosted by improving demand fundamentals and conservative Street expectations. The firm's checks indicate that the company's order pipelines are building, while its fundamentals have improved slightly. Pacific Crest does not think that the improvement is reflected in consensus estimates, and it keeps an Outperform rating on the shares.
08:26 EDTMDTMedtronic risk/reward attractive, says Morgan Stanley
Subscribe for More Information
06:42 EDTMDTObama to look to limit inversion deals, Politico says
Subscribe for More Information
August 6, 2014
18:54 EDTVMWOn The Fly: After Hours Movers
Subscribe for More Information
17:18 EDTHOLXHologic receives Canadian regulatory approval for Horizon DXA platform
Subscribe for More Information
16:08 EDTVMWVMware authorizes $1B stock repurchase program
VMware announced that its board has authorized the purchase of up to $1.0B of its class A common stock through the end of 2016. Stock will be purchased from time to time, in the open market or through private transactions, subject to market conditions. The company expects the equity purchase program to help partially offset dilution from its equity programs. The new stock repurchase authorization is in addition to the company's ongoing $700M stock repurchase program, originally announced August 7, 2013.
13:42 EDTMDTMedtronic says approval for Covidien deal 'progressing'
Subscribe for More Information
13:39 EDTMDTMedtronic CEO says Covidien deal should close end of year, early next
Subscribe for More Information
13:38 EDTMDTMedtronic CEO says 'progressing' in Covidien deal approval process
Subscribe for More Information
13:12 EDTTAT&T mulls buying CSN Houston, Bloomberg says
Subscribe for More Information
12:59 EDTMDTCovidien drops as Treasury explores ways to stymie inversions
Shares of medical device and drug maker Covidien (COV) are falling after multiple media outlets reported that the Treasury Department is looking into ways of curtailing tax inversion deals. Covidien has agreed to be acquired by Medtronic (MDT) in a tax inversion deal. BACKGROUND: Tax inversions refer to an acquisition of one company, usually officially based in a country in Europe or elsewhere, by a U.S. company, following which the acquiring company becomes domiciled in the same country as the company that it bought. The switch has the potential to significantly lower the acquiring company's tax rate. WHAT'S NEW: The Treasury Department is looking at options that would enable the Obama administration to curtail inversion deals without authorization from Congress, multiple media outlets reported last night and today. ANALYST REACTION: In a note to investors today, Wells Fargo analyst Larry Biegelsen wrote that he believes that Medtronic would buy Covidien even if the transaction cannot be done as an inversion. At a conference in June, Medtronic CFO Gary Ellis said that his company would "do the deal whether it's an inversion or not inversion," Biegelsen stated. If no inversion is possible, Medtronic would respond by using less of its stock and more debt to fund the transaction, the analyst believes. Such a change would actually cause Medtronic's cash earnings per share to be higher in the first and second year after the deal than under the current structure, the analyst indicated. He kept an Outperform rating on Medtronic. PRICE ACTION: In early afternoon trading, Covidien dropped 2% to $84.50 and Medtronic fell 1% to $61.50. Meanwhile, drug maker Shire (SHPG), which has agreed to merge with its peer AbbVie (ABBV) in a tax inversion deal, is falling 4% to $236.
12:20 EDTMDTMedtronic remains committed to Covidien deal, says Wells Fargo
Following recent conversations with the company, Wells Fargo believes Medtronic (MDT) remains committed to the acquisition Covidien (COV), even if the deal can't be structured as an inversion. The firm notes that at its conference in June, Medtronic CFO Gary Ellis stated that "from Medtronic's perspective, we would do the deal whether it's an inversion or not inversion." Wells adds, however, that Medtronic would likely try to renegotiate the terms of the deal if an inversion is not possible.
10:00 EDTCERNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:59 EDTCERNCerner management to meet with Deutsche Bank
Subscribe for More Information
07:36 EDTCERNCerner M&A deal should be largely accretive, says UBS
Subscribe for More Information
06:41 EDTMDTObama administration may restrict inversion tax benefits, NY Times says
Subscribe for More Information
06:23 EDTVARMitsubishi UFJ to hold a conference
Subscribe for More Information
06:21 EDTATHN, MDT, CERNPiper Jaffray to hold a summit
Subscribe for More Information
05:49 EDTCERNCerner upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use